AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17584705 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerine sublingual application
Number of subjects: 11
Study 15523717 — intervention group
Group type: EXPERIMENTAL
Intervention: SH U 555 C at 5 micromol Fe/kg b.w.
Number of subjects: 16
Study 15523717 — intervention group
Group type: EXPERIMENTAL
Intervention: SH U 555 C at 10 micromol Fe/kg b.w.
Number of subjects: 16
Study 15523717 — intervention group
Group type: EXPERIMENTAL
Intervention: SH U 555 C at 20 micromol Fe/kg b.w.
Number of subjects: 16
Study 15523717 — intervention group
Group type: EXPERIMENTAL
Intervention: SH U 555 C at 40 micromol Fe/kg b.w.
Number of subjects: 16
Study 15523717 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 16
Study 11175372 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal administration of 4-aminopyridine at 5 microg/h for 4-5 hours
Number of subjects: 6
Study 9122864 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (0.25%)
Number of subjects: 20
Study 9122864 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution (control group)
Number of subjects: 20
Study 9122864 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine combined with morphine
Number of subjects: 20
Study 1552460 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-phase oil:water mouthrinse (TPM)
Number of subjects: 60
Study 1552460 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthrinse
Number of subjects: 60
Study 1552460 — intervention group
Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 60
Study 3995960 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms sulprostone gel
Number of subjects: 60
Study 3995960 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms sulprostone gel
Number of subjects: 60
Study 3995960 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 micrograms sulprostone gel
Number of subjects: 60
Study 3995960 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical priming with sulprostone gel
Number of subjects: 60
Study 31063507 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-mediated low-intensity behavioural weight loss maintenance (WLM) programme
Number of subjects: 288
Study 31063507 — intervention group
Group type: COMPARATOR
Intervention: Standard lifestyle advice via newsletter (control arm)
Number of subjects: 288
Study 31063507 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-mediated low-intensity behavioural WLM programme
Number of subjects: 288
Study 28602825 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone Level Implants (OsseoSpeed TX, Astra tech)
Number of subjects: 32
Study 28602825 — intervention group
Group type: COMPARATOR
Intervention: Tissue Level Implants (RN SLActive®, Straumann)
Number of subjects: 32
Study 25804580 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated CXL (18 mW/cm², 5 minutes)
Number of subjects: 31
Study 25804580 — intervention group
Group type: COMPARATOR
Intervention: Standard CXL (3 mW/cm², 30 minutes)
Number of subjects: 31
Study 23469170 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 54
Study 23469170 — intervention group
Group type: COMPARATOR
Intervention: Control object
Number of subjects: 54
Study 21878431 — intervention group
Group type: EXPERIMENTAL
Intervention: IABC plus PCI
Number of subjects: 337
Study 21878431 — intervention group
Group type: COMPARATOR
Intervention: PCI alone
Number of subjects: 337
Study 18848869 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonau flash (Biolab Sanus Farmacêutica, Brazil)
Number of subjects: 23
Study 18848869 — intervention group
Group type: COMPARATOR
Intervention: Zofran (GlaxoSmithKline, Brazil)
Number of subjects: 23
Study 16809569 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 15
Study 16809569 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 15
Study 16809569 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive performance and electroencephalogram
Number of subjects: 15
Study 12770654 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 and Group 2 (children weighing less than 20 kg)
Number of subjects: 38
Study 12770654 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1
Number of subjects: 38
Study 10697373 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (250 mg/day)
Number of subjects: 28
Study 10697373 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiklid (500 mg/day)
Number of subjects: 28
Study 10697373 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiklid (500 mg/day) + Aspirin (250 mg/day)
Number of subjects: 28
Study 9351684 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 min 30 s test
Number of subjects: 9
Study 9351684 — intervention group
Group type: COMPARATOR
Intervention: 4 min test
Number of subjects: 9
Study 8222740 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn oil (6 g/day)
Number of subjects: 40
Study 8222740 — intervention group
Group type: COMPARATOR
Intervention: Fish oil preparation enriched with omega-3-PUFA (6 g/day, 2.0 g/day of omega-3-PUFA)
Number of subjects: 40
Study 8222740 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn oil and Fish oil preparation
Number of subjects: 40
Study 3896432 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine, 5 mg in 10 ml 0.9% NaCl
Number of subjects: 207
Study 3896432 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 10 ml 0.9% NaCl
Number of subjects: 207
Study 29617180 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk muscle training (TMT) and neuromuscular electrical stimulation (NMES)
Number of subjects: 1
Study 30412147 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-back hormone replacement therapy with mineral waters (MW) and radon therapy (RT) combined with triptorelin in the main group (MG)
Number of subjects: 89
Study 30412147 — intervention group
Group type: COMPARATOR
Intervention: Triptorelin treatment in the control group (CG)
Number of subjects: 89
Study 26891754 — intervention group
Group type: COMPARATOR
Intervention: FiO2 28%
Number of subjects: 31
Study 26891754 — intervention group
Group type: COMPARATOR
Intervention: FiO2 40%
Number of subjects: 31
Study 25473176 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fermentable, oligosaccharides, disaccharides, monosaccharides and polyols diet (LFD)
Number of subjects: 123
Study 25473176 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG)
Number of subjects: 123
Study 25473176 — intervention group
Group type: COMPARATOR
Intervention: Normal Danish/Western diet (ND)
Number of subjects: 123
Study 22522851 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Vitamin K 1.25mg
Number of subjects: 20
Study 22522851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 20642916 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal membrane oxygenation (ECMO)
Number of subjects: 180
Study 20642916 — intervention group
Group type: COMPARATOR
Intervention: Conventional management (CM)
Number of subjects: 180
Study 19063836 — intervention group
Group type: EXPERIMENTAL
Intervention: Andrographolide drop-pill (1.5 g, three times a day for 3 days)
Number of subjects: 478
Study 19063836 — intervention group
Group type: COMPARATOR
Intervention: Andrographolide tablet (1.5 g, three times a day for 3 days)
Number of subjects: 478
Study 15676038 — intervention group
Group type: EXPERIMENTAL
Intervention: Giona Easyhaler 200 microg/dose
Number of subjects: 33
Study 15676038 — intervention group
Group type: COMPARATOR
Intervention: Pulmicort Turbuhaler 200 microg/dose
Number of subjects: 33
Study 15676038 — intervention group
Group type: EXPERIMENTAL
Intervention: Charcoal administration (40 g)
Number of subjects: 33
Study 12507361 — intervention group
Group type: EXPERIMENTAL
Intervention: Sad mood induction
Number of subjects: 197
Study 12507361 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood induction
Number of subjects: 197
Study 9641332 — intervention group
Group type: EXPERIMENTAL
Intervention: GIA stapler and buttressed with bovine pericardial sleeves
Number of subjects: 30
Study 9641332 — intervention group
Group type: COMPARATOR
Intervention: TA 55 staplers alone
Number of subjects: 30
Study 9641332 — intervention group
Group type: COMPARATOR
Intervention: Cautery, clamps and silk ties
Number of subjects: 30
Study 8587086 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (NSAID) for 18 months
Number of subjects: 45
Study 8587086 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 18 months
Number of subjects: 45
Study 2802959 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral constant resistance computerized exercise equipment (concentric contractions)
Number of subjects: 46
Study 2802959 — intervention group
Group type: COMPARATOR
Intervention: Bilateral variable resistance exercise equipment (concentric and eccentric contractions)
Number of subjects: 46
Study 2802959 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control group
Number of subjects: 46
Study 1254792 — intervention group
Group type: EXPERIMENTAL
Intervention: Signal plus noise
Number of subjects: 0
Study 1254792 — intervention group
Group type: COMPARATOR
Intervention: Noise alone
Number of subjects: 0
Study 1254792 — intervention group
Group type: EXPERIMENTAL
Intervention: Defined observation intervals
Number of subjects: 0
Study 1254792 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-defined observation intervals
Number of subjects: 0
Study 31225645 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual face-to-face intervention focusing on protective factors
Number of subjects: 160
Study 31225645 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 160
Study 28954920 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline TQoL (transformed Quality of Life)
Number of subjects: 33357
Study 28954920 — intervention group
Group type: COMPARATOR
Intervention: Lowest baseline TQoL quartile
Number of subjects: 33357
Study 28954920 — intervention group
Group type: EXPERIMENTAL
Intervention: Poststroke TQoL change
Number of subjects: 33357
Study 28954920 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline TQoL
Number of subjects: 33357
Study 25940030 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolapitant 180 mg
Number of subjects: 454
Study 24363523 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux gastrojejunostomy
Number of subjects: 41
Study 24363523 — intervention group
Group type: COMPARATOR
Intervention: Conventional gastrojejunostomy
Number of subjects: 41
Study 21952611 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosapride citrate
Number of subjects: 28
Study 21952611 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 21952611 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient drinking test
Number of subjects: 28
Study 21952611 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric barostat study
Number of subjects: 28
Study 19420393 — intervention group
Group type: EXPERIMENTAL
Intervention: Saude na Boa intervention (environmental/organizational changes, physical activity education, personnel training and engagement)
Number of subjects: 20
Study 19420393 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 19420393 — intervention group
Group type: EXPERIMENTAL
Intervention: Saude na Boa intervention
Number of subjects: 20
Study 19420393 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 16958688 — intervention group
Group type: EXPERIMENTAL
Intervention: Early loading protocol (Group A) - overdenture connected 1 week after surgery
Number of subjects: 20
Study 16958688 — intervention group
Group type: COMPARATOR
Intervention: Conventional loading protocol (Group B) - overdenture connected after 12 weeks of healing
Number of subjects: 20
Study 15149513 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid microspheres loaded with 0.025% clobetasol propionate (formulation A)
Number of subjects: 45
Study 15149513 — intervention group
Group type: COMPARATOR
Intervention: Lipophilic ointment in a hydrophilic phase 0.025% (formulation B)
Number of subjects: 45
Study 11052430 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective mechanical ventilation (PV; respiratory rate, 16 breaths/min; tidal volume, 6 mL/kg; FIO2, 1.0; PEEP, +5)
Number of subjects: 25
Study 11052430 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CV; respiratory rate, 8 breaths/min; tidal volume, 12 mL/kg; FIO2, 1.0; PEEP, +5)
Number of subjects: 25
Study 9771950 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin (30 mg) plus Verapamil (15 mg)
Number of subjects: 157
Study 9771950 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin (30 mg) alone
Number of subjects: 157
Study 8155011 — intervention group
Group type: EXPERIMENTAL
Intervention: Lazabemide 100 mg/d
Number of subjects: 137
Study 8155011 — intervention group
Group type: EXPERIMENTAL
Intervention: Lazabemide 200 mg/d
Number of subjects: 137
Study 8155011 — intervention group
Group type: EXPERIMENTAL
Intervention: Lazabemide 400 mg/d
Number of subjects: 137
Study 8155011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study 3042215 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 18
Study 3042215 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin therapy (CIT)
Number of subjects: 18
Study 31203197 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudomonas aeruginosa eradication therapy
Number of subjects: 0
Study 29427913 — intervention group
Group type: EXPERIMENTAL
Intervention: l-carnosine (2 gr/day in two divided doses)
Number of subjects: 63
Study 29427913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 26913539 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger group size (more academic authors or MBA students)
Number of subjects: 0
Study 26913539 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit consideration of others' contributions
Number of subjects: 0
Study 25526495 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial liver support system (ALSS) plus standard medical therapy (SMT), n = 104
Number of subjects: 234
Study 25526495 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (SMT) alone, n = 130
Number of subjects: 234
Study 21800218 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance to empiric therapy for gram positive cocci and coliforms
Number of subjects: 229
Study 21800218 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of only gram positive cocci, predominantly Enterococcus spp.
Number of subjects: 229
Study 18665360 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab maintenance therapy (8 cycles of 375 mg/m² every 3 months)
Number of subjects: 122
Study 18665360 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 122
Study 17242421 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported medication adherence
Number of subjects: 0
Study 17242421 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported medication adherence <80%
Number of subjects: 0
Study 15648727 — intervention group
Group type: EXPERIMENTAL
Intervention: Arabic or Mandarin numerals naming, adding, or multiplying
Number of subjects: 0
Study 15648727 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnitude comparisons on pairs of Arabic or Mandarin numerals
Number of subjects: 0
Study 15648727 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory for arithmetic facts
Number of subjects: 0
Study 12353898 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resection and anterior transposition of the inferior oblique muscle
Number of subjects: 9
Study 10449017 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (25 g x d(‐1) for 1 week followed by 5 g x d(‐1) for 11 weeks)
Number of subjects: 19
Study 10449017 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 19
Study 10449017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 8526758 — intervention group
Group type: EXPERIMENTAL
Intervention: Arrhythmogenic zones
Number of subjects: 0
Study 8526758 — intervention group
Group type: COMPARATOR
Intervention: Non-arrhythmogenic zones
Number of subjects: 0
Study 2085577 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone iodine and nonocclusive dressings changed 2 to 3 times weekly
Number of subjects: 127
Study 2085577 — intervention group
Group type: COMPARATOR
Intervention: Nondisinfectant soap and water
Number of subjects: 127
Study 158569 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide gel 2.5%
Number of subjects: 200
Study 158569 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide gel 5%
Number of subjects: 200
Study 158569 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide gel (both strengths)
Number of subjects: 200
Study 6805715 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg
Number of subjects: 26
Study 6805715 — intervention group
Group type: COMPARATOR
Intervention: Pethidine 100 mg
Number of subjects: 26
Study 31973735 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid responsiveness assessment (FR+ vs FR-)
Number of subjects: 348
Study 31973735 — intervention group
Group type: COMPARATOR
Intervention: Fluid administration
Number of subjects: 348
Study 30598384 — intervention group
Group type: EXPERIMENTAL
Intervention: Farmed Atlantic salmon consumption (3 times weekly for 16 weeks)
Number of subjects: 205
Study 30598384 — intervention group
Group type: COMPARATOR
Intervention: Meat consumption (3 times weekly for 16 weeks)
Number of subjects: 205
Study 28759113 — intervention group
Group type: EXPERIMENTAL
Intervention: EN-DUR (exercise and nutrition intervention during RT)
Number of subjects: 41
Study 28759113 — intervention group
Group type: EXPERIMENTAL
Intervention: EN-AF (exercise and nutrition intervention after RT)
Number of subjects: 41
Study 28759113 — intervention group
Group type: COMPARATOR
Intervention: Comparison between EN-DUR and EN-AF
Number of subjects: 41
Study 27579824 — intervention group
Group type: EXPERIMENTAL
Intervention: Act on Threes educational intervention combined with standard care
Number of subjects: 6243
Study 27579824 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 6243
Study 24929782 — intervention group
Group type: EXPERIMENTAL
Intervention: Association Splitting (AS)
Number of subjects: 70
Study 24929782 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 70
Study 24929782 — intervention group
Group type: COMPARATOR
Intervention: Computerized cognitive training
Number of subjects: 70
Study 22709616 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Metacognitive Training (MCT)
Number of subjects: 19
Study 22709616 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 19
Study 19322115 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol releasing 0.014 mg estradiol (E2)/week
Number of subjects: 270
Study 19322115 — intervention group
Group type: COMPARATOR
Intervention: Raloxifene hydrochloride 60 mg/day
Number of subjects: 270
Study 17574455 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 21
Study 17574455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 15095035 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk powder equivalent to 1300 mg calcium
Number of subjects: 344
Study 15095035 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk powder equivalent to 650 mg calcium
Number of subjects: 344
Study 15095035 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 344
Study 11822993 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cocaine 150 mg
Number of subjects: 22
Study 11822993 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cocaine 200 mg
Number of subjects: 22
Study 11822993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 10078487 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 264
Study 10078487 — intervention group
Group type: COMPARATOR
Intervention: Control (meningococcal vaccine, pneumococcal vaccine, or placebo)
Number of subjects: 264
Study 8788313 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms octreotide
Number of subjects: 40
Study 8788313 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 2251976 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg BCH 069 (intravenous injection) 3 times weekly for 6 weeks
Number of subjects: 0
Study 2251976 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg BCH 069 (subcutaneous injection) 3 times weekly for 4 weeks
Number of subjects: 0
Study 2251976 — intervention group
Group type: COMPARATOR
Intervention: Placebo (subcutaneous injection) 3 times weekly for 4 weeks
Number of subjects: 0
Study 6103755 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxyprothepin decanoate
Number of subjects: 30
Study 6103755 — intervention group
Group type: COMPARATOR
Intervention: Fluphenazin decanoate
Number of subjects: 30
Study 31162787 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol sustained-release
Number of subjects: 34
Study 31162787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 28939607 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin-based decolonization therapy
Number of subjects: 95
Study 28939607 — intervention group
Group type: COMPARATOR
Intervention: Education control group
Number of subjects: 95
Study 28939607 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline MRSA isolates
Number of subjects: 95
Study 28939607 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months follow-up MRSA isolates
Number of subjects: 95
Study 28939607 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline multidrug resistance (MDR)
Number of subjects: 95
Study 28939607 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months follow-up MDR
Number of subjects: 95
Study 28939607 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural homes
Number of subjects: 95
Study 28939607 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial use
Number of subjects: 95
Study 28939607 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin use
Number of subjects: 95
Study 26297296 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention in health centers
Number of subjects: 1955